PMH81 Cost-Effectiveness Analysis of Antidepressants by the IQWIG in Germany

Value in Health - United Kingdom
doi 10.1016/j.jval.2011.08.379
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Cost Effectiveness Analysis of Antidepressants on Breast Cancer Patients: A Markov Modeling Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Cost-Effectiveness Assessment of Herpes Zoster Vaccination in Germany

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Pin67 - Cost-Effectiveness of Quadrivalent Influenza Vaccination in Germany

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cost-Effectiveness of Adalimumab for Rheumatoid Arthritis in Germany

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Cv3 - Cost-Effectiveness of Sacubitril/Valsartan in Germany: Applying the Efficiency Threshold

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pmd110 - Cost-Effectiveness of Immunoadsorption for Incompatible Kidney Transplantation in Germany

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cost-Effectiveness Analysis

Dental Abstracts
2012English

Cost-Effectiveness Analysis.

BMJ
1993English

The Limits of Cost-Effectiveness Analysis

Circulation. Cardiovascular quality and outcomes
MedicineCardiovascular MedicineCardiology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy